[go: up one dir, main page]

FR3090321B1 - Procédé de filtration du fibrinogène - Google Patents

Procédé de filtration du fibrinogène Download PDF

Info

Publication number
FR3090321B1
FR3090321B1 FR1873741A FR1873741A FR3090321B1 FR 3090321 B1 FR3090321 B1 FR 3090321B1 FR 1873741 A FR1873741 A FR 1873741A FR 1873741 A FR1873741 A FR 1873741A FR 3090321 B1 FR3090321 B1 FR 3090321B1
Authority
FR
France
Prior art keywords
fibrinogen
filtration
elution
filtration process
fibrinogen composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1873741A
Other languages
English (en)
Other versions
FR3090321A1 (fr
Inventor
Damien Bataille
Monique Ollivier
Michel Tellier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LFB SA
Original Assignee
LFB SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR1873741A priority Critical patent/FR3090321B1/fr
Application filed by LFB SA filed Critical LFB SA
Priority to MA054552A priority patent/MA54552A/fr
Priority to PCT/FR2019/053235 priority patent/WO2020128385A1/fr
Priority to MX2021007553A priority patent/MX2021007553A/es
Priority to US17/416,143 priority patent/US20220056107A1/en
Priority to EP19848895.9A priority patent/EP3897692A1/fr
Publication of FR3090321A1 publication Critical patent/FR3090321A1/fr
Priority to CONC2021/0009000A priority patent/CO2021009000A2/es
Application granted granted Critical
Publication of FR3090321B1 publication Critical patent/FR3090321B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/022—Filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/04—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/08—Radiation
    • A61L2/081—Gamma radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/08—Radiation
    • A61L2/10—Ultraviolet radiation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
    • B01D15/361—Ion-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
    • B01D15/3804—Affinity chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
    • B01D15/3847—Multimodal interactions
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/02—Reverse osmosis; Hyperfiltration ; Nanofiltration
    • B01D61/027—Nanofiltration
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/02—Reverse osmosis; Hyperfiltration ; Nanofiltration
    • B01D61/04—Feed pretreatment
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/58—Multistep processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • A61L2103/05—
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2311/00—Details relating to membrane separation process operations and control
    • B01D2311/04—Specific process operations in the feed stream; Feed pretreatment
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2311/00—Details relating to membrane separation process operations and control
    • B01D2311/26—Further operations combined with membrane separation processes
    • B01D2311/2697—Chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2315/00—Details relating to the membrane module operation
    • B01D2315/16—Diafiltration
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14—Ultrafiltration; Microfiltration
    • B01D61/145—Ultrafiltration

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Water Supply & Treatment (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)

Abstract

Procédé de filtration d’une composition de fibrinogène, comprenant les étapes suivantes:a) purification par chromatographie de la composition de fibrinogène à l’aide d’un tampon d’élution comprenant de l’arginine ; b) optionnellement, au moins une étape de filtration de la composition de fibrinogène obtenue par élution de chromatographie à l’étape a), sur filtre ayant une taille de pores comprise entre 0,08 µm et 0,22 µm, c) filtration de la composition de fibrinogène obtenue par élution de chromatographie à l’étape a),ou optionnellement obtenue en b), sur filtre symétrique ayant une taille de pores comprise entre 15 nm et 25 nm, de préférence comprise entre 18 nm et 22 nm, et d) récupération de la solution résultante de fibrinogène,ledit procédé de filtration étant réalisé à une capacité élevée et sans étape préalable de congélation et/ou décongélation
FR1873741A 2018-12-21 2018-12-21 Procédé de filtration du fibrinogène Active FR3090321B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR1873741A FR3090321B1 (fr) 2018-12-21 2018-12-21 Procédé de filtration du fibrinogène
PCT/FR2019/053235 WO2020128385A1 (fr) 2018-12-21 2019-12-20 Procédé de filtration du fibrinogène
MX2021007553A MX2021007553A (es) 2018-12-21 2019-12-20 Procedimiento de filtracion del fibrinogeno.
US17/416,143 US20220056107A1 (en) 2018-12-21 2019-12-20 Method for Filtering Fibrinogen
MA054552A MA54552A (fr) 2018-12-21 2019-12-20 Procédé de filtration du fibrinogène
EP19848895.9A EP3897692A1 (fr) 2018-12-21 2019-12-20 Procédé de filtration du fibrinogène
CONC2021/0009000A CO2021009000A2 (es) 2018-12-21 2021-07-08 Procedimiento de filtración del fibrinógeno

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1873741A FR3090321B1 (fr) 2018-12-21 2018-12-21 Procédé de filtration du fibrinogène

Publications (2)

Publication Number Publication Date
FR3090321A1 FR3090321A1 (fr) 2020-06-26
FR3090321B1 true FR3090321B1 (fr) 2023-07-14

Family

ID=66542430

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1873741A Active FR3090321B1 (fr) 2018-12-21 2018-12-21 Procédé de filtration du fibrinogène

Country Status (7)

Country Link
US (1) US20220056107A1 (fr)
EP (1) EP3897692A1 (fr)
CO (1) CO2021009000A2 (fr)
FR (1) FR3090321B1 (fr)
MA (1) MA54552A (fr)
MX (1) MX2021007553A (fr)
WO (1) WO2020128385A1 (fr)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10211632A1 (de) * 2002-03-15 2003-10-09 Aventis Behring Gmbh Verfahren zur Abtrennung von Viren aus einer Proteinlösung durch Nanofiltration
ES2214967B1 (es) 2003-03-06 2005-06-16 Probitas Pharma, S.A Procedimiento para la eliminacion de virus en soluciones de fibrinogeno y fibrinogeno obtenido por dicho procedimiento.
FR2887883B1 (fr) 2005-06-29 2007-08-31 Lab Francais Du Fractionnement Procede de separation des proteines fibrinogene, facteur xiii et colle biologique d'une fraction plasmatique solubilisee et de preparation de concentres lyophilises desdites proteines
WO2009155626A2 (fr) * 2008-06-23 2009-12-30 Bio-Products & Bio-Engineering Ag Fibrinogène fonctionnellement intact stable au stockage
US10188965B2 (en) 2012-12-05 2019-01-29 Csl Behring Gmbh Hydrophobic charge induction chromatographic depletion of a protein from a solution
US20140154233A1 (en) * 2012-12-05 2014-06-05 Csl Limited Method of purifying therapeutic proteins
CN105452291B (zh) * 2013-08-08 2019-03-19 杰特有限公司 去除污染物的方法
FR3018450B1 (fr) 2014-03-11 2016-04-15 Lab Francais Du Fractionnement Procede de preparation de proteines plasmatiques humaines
JP2019524704A (ja) 2016-07-06 2019-09-05 ラボラトワール・フランセ・デュ・フラクシオンマン・エ・デ・ビョテクノロジーＬａｂｏｒａｔｏｉｒｅ Ｆｒａｎｃａｉｓ Ｄｕ Ｆｒａｃｔｉｏｎｎｅｍｅｎｔ Ｅｔ Ｄｅｓ Ｂｉｏｔｅｃｈｎｏｌｏｇｉｅｓ 安定な液体フィブリノーゲン

Also Published As

Publication number Publication date
FR3090321A1 (fr) 2020-06-26
MA54552A (fr) 2022-03-30
US20220056107A1 (en) 2022-02-24
MX2021007553A (es) 2021-08-11
EP3897692A1 (fr) 2021-10-27
CO2021009000A2 (es) 2021-07-30
WO2020128385A1 (fr) 2020-06-25

Similar Documents

Publication Publication Date Title
JP5778389B2 (ja) たんぱく質の精製方法
Schwartz et al. Introduction to tangential flow filtration for laboratory and process development applications
US11905311B2 (en) System and method for producing interleukin receptor antagonist (IRA)
CA2381208C (fr) Membranes filtrantes de solution pour substances physiologiquement actives
JP2023022241A (ja) 治療用の細胞および組成物の調製における決定論的横置換
Chernyshev et al. Asymmetric depth‐filtration: A versatile and scalable method for high‐yield isolation of extracellular vesicles with low contamination
CR9582A (es) Metodos para purificar anticuerpos anti a beta
JP2014526246A5 (fr)
Hamzah et al. High performance of polysulfone ultrafiltration membrane: Effect of polymer concentration
MA31302B1 (fr) Filtre microporeux ayant une source anti-microbienne
RU2021119421A (ru) Способы обработки текучей среды, содержащей рекомбинантный терапевтический белок, и их применение
RU2010130541A (ru) Обработка биотоплив
WO1994022904A1 (fr) Perfectionnements apportes a la separation de proteines
AR124932A1 (es) Regeneración y uso múltiple de filtros de clarificación
JP2017066146A (ja) 中空糸膜を使用しての剪断感受性バイオポリマーを濃縮する方法
CN104968408A (zh) 过滤装置以及使用该过滤装置的方法
SE0401951D0 (sv) Chromatography method
FR3090321B1 (fr) Procédé de filtration du fibrinogène
SE0300482D0 (sv) Inorganic beads with hierarchical pore structures
EP3371302B1 (fr) Procédé de purification de compositions de virus et de telles compositions obtenues
KR20180006462A (ko) 미립자 동결건조된 혈소판 용해물 조성물
DK1534404T3 (da) Anvendelse af en klatratmodifikator til at fremme passagen af proteiner under nanofiltrering
WO2019174480A1 (fr) Colonne d'extraction et de filtration d'acide nucléique
GB2348886A (en) Virus or viral antigen purification method and vaccine producing method
FR3072506B1 (fr) Procede de fabrication en continu d'une electrode

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20200626

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

CA Change of address

Effective date: 20221108

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8